US · MBOT
Microbot Medical Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Hingham, MA 02043
- Website
- microbotmedical.com
Price · as of 2024-12-31
$2.10
Market cap 109.82M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $13,122.00 | $5,248.80 | $46,232.33 | $0.00 | $0.00 |
| 2011 | $1,701.00 | $2,931.75 | $0.00 | $0.00 | $13,745.55 |
| 2012 | $2,948.40 | $1,457.11 | $0.00 | $0.00 | $0.00 |
| 2013 | $2,494.80 | $998.02 | $501.19 | $0.00 | $3,302.38 |
| 2014 | $2,008.80 | $806.05 | $0.00 | $0.00 | $6,011.19 |
| 2015 | $421.20 | $14,906.97 | $0.00 | $0.00 | $38,000.68 |
| 2016 | $92.55 | $882.01 | |||
| 2017 | $12.60 | ||||
| 2018 | $7.65 | ||||
| 2019 | $7.97 | ||||
| 2020 | $8.91 | ||||
| 2021 | $5.11 | ||||
| 2022 | $2.38 | ||||
| 2023 | $1.28 | ||||
| 2024 | $1.45 |
AI valuation
Our deep-learning model estimates Microbot Medical Inc.'s (MBOT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $2.10
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MBOT | Microbot Medical Inc. | $2.10 | 109.82M | — | — | — | — | -1.98 | 6.43 | — | -1.53 | — | 6.43 | 0.00% | — | — | -284.97% | 667.72% | -159.40% | 0.03 | — | 2.37 | 2.35 | 0.26 | -3048.00% | — | 334.00% | -39.02% | -3.59 | 508.44% | 0.00% | 0.00% | 3.38% | -1.49 | -1.96 | — | -21.36 |
| CLNN | Clene Inc. | $5.23 | 48.62M | +633% | -65% | — | +3,976% | -0.81 | -3.60 | 93.13 | -1.20 | — | -3.60 | 79.53% | -9676.32% | -11520.47% | -1738.36% | -637.51% | -98.90% | -2.35 | -8.14 | 1.57 | 1.22 | -0.26 | -3987.00% | -4771.00% | -3003.00% | -67.00% | -2.07 | -411.12% | 0.00% | 0.00% | 0.00% | -1.22 | -1.90 | 118.53 | -17.65 |
| CNTX | Context Therapeutics Inc. | $2.25 | 206.73M | — | — | — | — | -1.75 | 0.49 | — | 1.59 | — | 0.49 | 0.00% | — | — | -49.89% | 3929.63% | -46.81% | 0.00 | — | 35.62 | 34.36 | 3.15 | -6933.00% | — | 3927.00% | -62.65% | -5.30 | 3849.40% | 0.00% | 0.00% | 170.46% | 1.58 | 1.62 | — | 8.62 |
| CRDL | Cardiol Therapeutics Inc. | $1.02 | 113.91M | — | — | — | — | -3.18 | 4.71 | — | -2.15 | -19.96 | 4.71 | 0.00% | — | — | -138.47% | 660.06% | -106.99% | 0.01 | — | 4.52 | 4.41 | 0.76 | 1591.00% | — | -64.00% | -21.53% | -3.58 | 411.05% | 0.00% | 0.00% | 0.00% | -2.14 | -3.43 | — | -1.32 |
| DCGO | DocGo Inc. | $0.72 | 70.23M | +14,095,114% | +69% | — | +90% | 15.52 | 0.97 | 0.50 | 6.11 | 8.75 | 1.25 | 34.64% | 4.65% | 3.24% | 6.43% | 4.79% | 4.23% | 0.18 | 13.24 | 2.50 | 2.46 | -0.70 | 17735.00% | -124.00% | -18676.00% | 20.79% | 0.58 | 22.36% | 417209.23% | 6474653.60% | 417219.88% | 9.70 | 4.31 | 0.45 | 3.36 |
| NSPR | InspireMD, Inc. | $1.78 | 75.42M | +1,242% | -35% | — | — | -3.72 | 3.30 | 16.99 | -2.61 | — | 3.30 | 21.49% | -478.00% | -456.63% | -84.68% | -1143.45% | -67.77% | 0.06 | — | 5.28 | 4.80 | 0.50 | -732.00% | 1296.00% | 3887.00% | -19.54% | -2.85 | -794.20% | 0.00% | 0.00% | 7.17% | -2.59 | -3.73 | 12.38 | -2.29 |
| ORMP | Oramed Pharmaceuticals In… | $3.42 | 136.08M | +1,195% | — | — | — | -5.13 | 0.67 | — | 2.94 | — | 0.67 | 0.00% | — | — | -12.29% | -43.99% | -10.14% | 0.00 | -14.98 | 25.19 | 24.97 | 3.63 | -43571.00% | -10000.00% | -2009.00% | -8.62% | -1.48 | -29.02% | 0.00% | 0.00% | 101.31% | 3.42 | 5.19 | — | 5.11 |
| OVID | Ovid Therapeutics Inc. | $1.63 | 116.08M | +1,596% | -87% | — | — | -1.39 | 0.54 | 65.14 | 0.03 | — | 0.54 | 100.00% | -10933.75% | -4670.14% | -33.88% | -444.08% | -22.38% | 0.22 | — | 5.32 | 5.04 | 0.20 | -5000.00% | 4439.00% | 2201.00% | -151.96% | -5.32 | -402.05% | 0.00% | 0.00% | 1.37% | 0.02 | 0.03 | -2.56 | -5.32 |
| RCEL | AVITA Medical, Inc. | $5.03 | 124.96M | +486% | -58% | — | — | -3.02 | -8.82 | 2.05 | -3.30 | — | -6.59 | 82.13% | -58.56% | -67.85% | 799.72% | 463.33% | -71.40% | -0.13 | -8.38 | 0.57 | 0.44 | 0.20 | -2720.00% | 1145.00% | -4647.00% | -21.25% | -0.50 | 344.68% | 0.00% | 0.00% | 27.27% | -3.12 | -4.19 | 1.83 | -10.70 |
| VANI | Vivani Medical, Inc. | $1.23 | 72.67M | — | — | — | — | -2.53 | 3.37 | — | -2.49 | — | 3.37 | 0.00% | — | — | -122.42% | -125.35% | -53.77% | 1.10 | — | 3.41 | 3.11 | -0.04 | -1400.00% | — | -1319.00% | -35.94% | -3.47 | -108.41% | 0.00% | 0.00% | 0.00% | -2.45 | -2.83 | — | -4.16 |
| ZTEK | Zentek Ltd. | $0.59 | 63.47M | +50,246% | +2% | — | — | -21.35 | 14.54 | 245.72 | -22.99 | — | 14.54 | 22.06% | -1100.37% | -1150.68% | -67.74% | -67.33% | -57.26% | 0.05 | -105.13 | 1.25 | 0.38 | -0.06 | -1667.00% | 282626.00% | 168.00% | -2.93% | -1.80 | -44.07% | 0.00% | 0.00% | 0.00% | -22.39 | -34.21 | 246.36 | 27.27 |
About Microbot Medical Inc.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
- CEO
- Harel Gadot
- Employees
- 20
- Beta
- 1.29
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $2.10) − 1 = — (DCF, example).